Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the association of non-alcoholic fatty liver disease and diabetes mellitus. Patients presenting in our clinic with Diabetes mellitus type 1 or 2 will receive the following examination: - Transient Elastography and Controlled Attenuation Parameter using the FibroScan - blood examination including biochemical markers The statistically calculated sample size needed is 340 patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01997424
Study type Interventional
Source Johann Wolfgang Goethe University Hospital
Contact
Status Completed
Phase N/A
Start date May 2013
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04099147 - Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.
Completed NCT04019561 - A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH. Phase 2
Withdrawn NCT00375349 - Non Alcoholic Fatty Liver Disease Influence of Statin Therapy N/A
Active, not recruiting NCT04682600 - The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF N/A
Terminated NCT02605616 - Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD) Phase 2
Completed NCT04165343 - Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER
Recruiting NCT03151473 - Longitudinal Observational Study Of Chinese With NAFLD/NASH
Recruiting NCT04820036 - A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG) N/A
Active, not recruiting NCT02037321 - Meta-Analyses of the Effect of Vegetable Protein for Animal Protein on Cardiometabolic Risk N/A
Completed NCT01110577 - Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171) N/A
Completed NCT00771108 - Exercise Dose and Nonalcoholic Fatty Liver Disease N/A
Recruiting NCT04639414 - Combined Active Treatment in Type 2 Diabetes With NASH Phase 4
Completed NCT04450875 - Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLD N/A
Recruiting NCT02654665 - Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults Phase 3
Recruiting NCT05699018 - Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients N/A
Withdrawn NCT02457286 - Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study Phase 1
Withdrawn NCT02194894 - The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients N/A
Completed NCT01811472 - Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients Phase 2
Completed NCT00968747 - Regulation of FGF21 by Nutritional Challenges N/A
Recruiting NCT04330326 - Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease Phase 2